Compare

    Two terms, side by side

    Pick any two terms to see definitions, context, pitfalls, and sources in parallel.

    Curated comparison tables

    In-depth, attribute-by-attribute tables for the most common MedTech term pairs. Each row is sourced from the linked term pages.

    Reimbursement

    Category III CPT Code

    In one line
    Temporary CPT code for emerging technologies and services.
    Definition
    Category III CPT codes are temporary alphanumeric codes (ending in 'T') that track utilization of new or emerging procedures for which insufficient data exists for Category I designation. Codes sunset after five years if not converted or renewed. Category III codes are released twice a year, in January and July, so new technology can get tracking codes faster than the annual Category I cycle. Payers decide coverage individually, and many treat these procedures as investigational. Building published evidence and specialty society support during the five-year window is key to moving to Category I.
    Why it matters
    Often the first formal CPT pathway for a novel device-enabled procedure. Payment is at payer discretion; many commercial payers deny Category III claims as investigational.
    Common pitfalls
    • •Misinterpreting Category III CPT codes as a guarantee of reimbursement, as payment remains at payer discretion and is often denied given the 'investigational' status.
    • •Failing to recognize the temporary nature of Category III CPT codes; they sunset after five years if not converted to Category I or renewed.
    • •Neglecting to collect robust clinical data during the Category III phase, which is crucial for demonstrating efficacy and eventually achieving Category I CPT code status and broader reimbursement.
    • •Assuming that FDA clearance or approval automatically leads to CPT codes and reimbursement; these are separate processes with distinct criteria.
    Open full page
    Select term B to compare.

    Why compare MedTech terms side by side?

    MedTech terminology is full of pairs that look interchangeable but carry very different regulatory, clinical, and commercial consequences. Picking the wrong framework, pathway, or standard early in a project can add months to a submission, invalidate clinical evidence, or trigger an audit finding. Side-by-side comparison is the fastest way to surface those differences before they become costly mistakes.

    Each comparison on this page pulls from the same vendor-neutral, sourced definitions used throughout the MedTech Terms glossary. You see the one-line summary, the formal definition, why it matters in practice, common pitfalls, and the primary sources (FDA guidance, EU MDR/IVDR articles, ISO/IEC standards, MDCG documents, IMDRF principles) that back each entry. That makes the comparison defensible in regulatory strategy memos, design reviews, and submission narratives.

    Common comparison patterns

    How to use this tool

    Pick term A and term B from the dropdowns, or click a preset above. The URL updates with both slugs so you can bookmark or share the exact comparison with a colleague, a notified body reviewer, or your regulatory consultant. Click Open full page on either side for the complete entry, including FAQs, related terms, and the full citation list. If you are not sure which term to start with, browse the Categories view or the A-Z index.

    MedTech Terms is a vendor-neutral community resource sponsored by Blue Goat Cyber. Definitions are written for educational use and are not legal or regulatory advice.